Quantifying eosinophil cationic protein with ImmunoCAP ECP results in the proper evaluation of asthma patients. You can learn more about the clinical value, expected test values and test principle of ImmunoCAP ECP here.

ImmunoCAP ECP measures the level of Eosinophil Cationic Protein (ECP) in serum. Eosinophils are the cells chiefly responsible for producing the inflammation associated with asthma. When eosinophils in the airway are activated, they undergo degranulation, causing airway epithelial damage. This can lead to chronic inflammatory disease of the airway.

Clinical value

Asthmatic patients with eosinophilic inflammation have elevated levels of ECP in serum and other body fluids such as bronchial alveolar fluid and (induced) sputum. A high level of serum ECP indicates inflammation, which is a risk factor for asthmatic patients.

Asthma therapy consists of suppressing chronic and persistent airway inflammation. Measuring ECP in a serum sample is an objective and direct way of estimating the severity of the airway inflammation and following the course of the disease.

ECP serum measurements can be used:

  • For monitoring inflammation in asthma
  • For guiding corticosteroid treatment in asthma
  • For finding non-compliant patients

Expected test values

Normal adult values have a geometric mean of 5.5 µg/l and a 95th percentile of 13.3 µg/l. Values over 15 µg/l should be considered elevated. However, patients should be their own control during treatment follow-up. 

Specimen collection and preparation

Parameters such as blood collection tube, coagulation time and temperature must be kept within specified limits because they affect the concentration of released ECP in serum samples. The clotting represents the first incubation in the assay, in which the ECP measured is to be reproducibly released from the eosinophils activated by the inflammation.

  1. Collect blood by venipuncture using Terumo Venosafe Serum-Gel tubes. It is important that the tube be completely filled. Contact Phadia AB if a serum collection tube other than Venosafe is to be used.
  2. After collection, gently invert the tube several times. Do not shake or vortex the tube.
  3. Release ECP by clotting for 60-120 minutes at room temperature (20-24 °C). For comparable results, the temperature must not vary more than ±1 °C between samplings.
  4. Centrifuge at 1000–1300 g for 10 minutes at room temperature.
  5. Decant the serum into a new tube.
  6. Serum samples may be kept at room temperature for shipping purposes. Otherwise store at 2-8 °C if assayed within five days after collection, or at -20 °C if assayed later.

Note  Plasma and haemolyzed serum cannot be used.

Important note

As in all diagnostic testing, a definitive clinical diagnosis should not be based solely on the results of a single test method. A diagnosis should be made by the doctor after the evaluation of all clinical and laboratory findings.